Some anticancer drugs, such as epidoxorubicin, increase CXCL1 expression in bladder cancer cells [39], which leads to the EMT of cancer cells and the production of metastasis as a side effect of therapy. This evidence concerns the gene CXCL1 and urinary bladder cancer.